AFP announces new bureau in North Korea
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
Istanbul (AFP) | 12/07/2025 - 10:34:24 | Erdogan says 'Turkey has won' after Kurdish PKK fighters disarm
Kyiv (AFP) | 12/07/2025 - 09:47:21 | Ukraine says Russia fired 623 drones and missiles
Gaza City (AFP) | 12/07/2025 - 08:58:29 | Gaza ceasefire talks held up by Israel withdrawal plans: Palestinian sources
Washington (AFP) | 12/07/2025 - 00:13:53 | US sanctions Cuban president four years after historic protests
New Delhi (AFP) | 11/07/2025 - 23:31:35 | Fuel to Air India jet engines cut off moments before crash: probe
Quito (AFP) | 11/07/2025 - 22:54:55 | Ecuador's top drug lord agrees to US extradition
Washington (AFP) | 11/07/2025 - 20:09:25 | US appeals court scraps 9/11 mastermind's plea deal
Istanbul (AFP) | 11/07/2025 - 18:33:18 | PKK disarmament marks 'new era' for resolving Kurdish question: pro-Kurdish DEM party
Moscow (AFP) | 11/07/2025 - 17:09:18 | Russia's FM Lavrov arrives in North Korea: Russian state media
Istanbul (AFP) | 11/07/2025 - 16:32:46 | Erdogan hails 'important step towards terror-free Turkey' as PKK destroys arms
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
AFP takes part to the 7th photography festival in Leipzig f/stop, Germany, from June 25th until July 3rd, 2016.
The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO’s strategic direction and ensure the organization’s continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape. This press release features multimedia. View the full rel...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive ...